The QualityStocks Daily Monday, February 25th, 2019

Today's Top 3 StockMarketWatch

The Street (ONCE) +120.09%

MarketClub Analysis (CIFS) +118.75%

QualityStocks (TECR) +97.04%

The QualityStocks Daily Stock List

TechCare Corp. (TECR)

InvestorsHub, MarketWatch, Stockhouse, OTC Markets, Investing, 4-Traders, GuruFocus, Morningstar, YCharts, Penny Stock Tweets, PR Newswire, Investors Hangout, Seeking Alpha, Wallet Investor, Stockwatch, Barchart, last10k, Dividend Investor, Emerging Growth, and Market Screener reported earlier on TechCare Corp. (TECR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

TechCare Corp. has an inventive delivery platform that utilizes vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this unique delivery platform using vaporization of different natural, plant-based compounds, to enable a wide variety of treatment solutions. A technology company and OTCQB-listed, TechCare is based in New York City.

The Company has a strategic partnership agreement with HoMedics, one of the world's leading brands in health and wellness products. HoMedics manufactures, markets, and distributes TechCare's Novokid products in the United States, Canada, Brazil, Argentina, Colombia, and Costa Rica. These products are co-branded as HoMedics products powered by TechCare.

Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap. Novokid is 100 percent natural, plant-based and pesticide-free. Novokid is the first of its type home use device. It presents a scientifically proven solution to eliminate lice, super lice, as well as eggs.

Novokid uses a proprietary vapor-based delivery platform. TechCare’s Novokid has received CE Mark approval as a CLASS I Medical Device. Novokid uses a simple 10-minute dry treatment. The treatment requires no rinsing or washing and is fast, dry, and clean. It is easily administered at home or while mobile. In addition, Novokid can be used as a maintenance and preventative treatment if used regularly.

The Company’s Shine is a hair treatment device. It underwent development with globally renowned industry leaders. Shine cleanses the hair and scalp. It also rejuvenates hair by returning its natural health, shine, body and luster. The expectation is that Shine will launch later in 2019.

TechCare announced in May of 2018 that following intensive research and development (R&D) and investments, it expanded its existing Intellectual Property (IP) portfolio with a previously submitted patent application of its Smart Capsule™ technology. Building upon its existing patents and knowledge, the new Smart Capsule™ technology enables the vaporization of two or more compounds simultaneously. As a result, this expands the range of applications while yielding superior performance, usability and ease-of-use.

Last month, TechCare announced that on January 21, 2019, it entered into a joint venture (JV) contract with China-Israel Biological Technology Co. Ltd. (CIB). With this agreement, TechCare's subsidiary Novomic Ltd. and CIB agreed to create a Chinese JV company in China.

The JV will concentrate on the field of health and cosmetics, including medical care, home care, hair care, and body and skin care, to develop a comprehensive and extensive range of health, wellness, beauty and home products for customers by using TechCare's patented technology of vaporization of natural and plant-based compounds. The JV’s intention is to sell its products in the Greater China region, including mainland China, Hong Kong, Macao and Taiwan, directly or through others.

TechCare Corp. (TECR), closed Monday's trading session at $0.16, up 97.04%, on 42,533 volume with 16 trades. The average volume for the last 3 months is 5,298 and the stock's 52-week low/high is $0.0401/$0.75.

chart

Isodiol International, Inc. (ISOLF)

SmallCapPower, Investors News, OTC Markets, Wallet Investor, Barchart, MarketWatch, Investopedia, Stockhouse, Stockwatch, Morningstar, Trading View, Wealth Daily, Investing News, MicroSmallCap, Proactive Investors, The Street, InvestorsHub, and GuruFocus reported earlier on Isodiol International, Inc. (ISOLF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. Its growth strategy includes the development of Over-the-Counter (OTC) and pharmaceutical drugs and expanding its phytoceutical portfolio. Be Trū Wellness is a wholly-owned subsidiary of the Company. Isodiol is continuing international expansion into Latin America, Asia, and Europe. A global CBD innovator and OTCQB-listed, Isodiol International is headquartered in Vancouver, British Columbia.

Isodiol International specializes in hemp-based health and wellness products and the development of pharmaceutical CBD delivery methods. In addition, the Company specializes in the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs).

Isodiol is the market leader in pharmaceutical grade phytochemical compounds. It is also the industry leader in the manufacturing and development of phytoceutical consumer products. Isodiol produces raw ingredients, consumer packaged goods, including dietary supplements, food and beverages, skin care, and pharmaceutical products for the worldwide healthcare market.

Regarding raw ingredients, Isodiol develops natural phytoceutical derivatives and delivery technologies. Additionally, it develops white label products and brands for wholesale customers. Concerning pharmaceuticals, the Company supplies raw phytoceutical ingredients. Pertaining to consumer products, it develops its own family of product brands for retail sale.

Isodiol has its ImmunAG™. This product is the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, thus creating greater bioactivity.

Isodiol has acquired global licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.

Last week, Isodiol International announced the acquisition of the CBD Naturals® beverage brands and intellectual property (IP) portfolio. This includes Hemp Rain, Rasa, Bliss Me, Fast CBD, and Simplex. This deal includes additional financing from the Company’s founder, Jared Berry, to be used for guaranteed product placement in greater than 1,000 U.S. retail locations. The transactions include the transfer to Isodiol International’s subsidiaries of substantially all of the IP and inventory of Carlsbad Naturals LLC, a Wyoming limited liability company (Carlsbad WY), and Carlsbad Naturals LLC, a New Mexico limited liability company (Carlsbad NM).

Isodiol International, Inc. (ISOLF), closed Monday's trading session at $0.9819, down 1.67%, on 142,182 volume with 81 trades. The average volume for the last 3 months is 242,812 and the stock's 52-week low/high is $0.7833/$12.00.

chart

American Green, Inc. (ERBB)

Insider Financial, Best Medical Marijuana Stocks, Morningstar, YCharts, Daily Marijuana Observer, InvestorsHub, Wall Street Alerts, Guru Focus, MarketWatch, Stockhouse, otc.watch, Wallet Investor, Seeking Alpha, Market Screener, Awesome Penny Stocks, New Cannabis Ventures, Barchart, and Marijuana Stocks reported earlier on American Green, Inc. (ERBB), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

American Green, Inc. operates the U.S. as a technology company in the medical cannabis industry. It became one of the first publicly traded technology companies in the medical cannabis industry globally, beginning in 2009, with the introduction of the ZaZZZ machine for automated, age-verifying dispensing of cannabis-based medicines. American Green’s dedication is to the developing cannabis market. The Company is based in Phoenix, Arizona.

American Green has its AGM verified vending system. The Company enables businesses to securely vend age-restricted products. This includes cannabis, beer, tobacco, pharmaceuticals, and more.

American Green has a state-of-the-art cultivation facility in Phoenix. Furthermore, it is involved with the sale or creation of a number of apps supporting cannabis and small businesses alike. This includes the Blaze Now dispensary locator that can be found in the Apple and Android app stores, as well as the Company’s Xpress app.

In September 2017, American Green purchased the desert town of Nipton, California. In October, it announced that it completed Phase One of its integration into Nipton. The Company’s stated goal for the town's future is for it to become the first energy-independent cannabis-friendly town in America. The new focus for the Town of Nipton is as a host location for cannabis tourism and a center for art and nature educational workshops.

American Green entered into a Joint Venture (JV) to form a CBD processing plant in Nipton with MediaTechnics Corporation (MEDT). With this JV, MEDT is to specify, procure, design, develop and install a state-of-the-art extraction facility in Nipton that can extract Cannabidiol (CBD) from Industrial Hemp.

American Green also completed its acquisition of Delta International Oil and Gas (DLTZ) through the sale of its Nipton assets. As a result, American Green gained control of Delta. Delta operates as a subsidiary of American Green. The expectation is that Delta International will invest heavily in Nipton and other American Green-run projects.

American Green announced in June 2018 that its state-of-the-art, 12,000 square foot medical cannabis grow facility opened in Phoenix. The facility commenced operations immediately. All products produced sell through American Green’s licensed grow partner, Natural Herbal Remedies.

American Green announced in 2018 that it entered into a Memorandum of Understanding (MOU) to create American Green Films, LLC. This is to produce commercial motion pictures, the first of which will use Nipton as its central location.

American Green announced in August of 2018 that its subsidiary, Delta International Oil & Gas, changed its name to CannAwake Corporation with the new stock symbol (CANX). American Green and CannAwake have completed the purchase of the solar power generating station in Nipton, California.

Last month, American Green announced that the cannabis grow operation it manages for its Licensee, Natural Herbal Remedies, was anticipated to reach full production in January. This 12,000 sq. ft. grow operation, on the west side of Phoenix, was years in the making because of numerous State and local licensing, permitting, and building modification issues. However, according to Mr. David Gwyther, American Green’s President, “It was worth the wait. The facility, which we call “Sweet Virginia,” is now turning out some of the best cannabis in the state of Arizona!”

American Green, Inc. (ERBB), closed Monday's trading session at $0.0003, even for the day, on 173,515,073 volume with 153 trades. The average volume for the last 3 months is 149,462,869 and the stock's 52-week low/high is $0.000197/$0.0014.

chart

Digerati Technologies, Inc. (DTGI)

Emerging Growth, Zacks, MarketWatch, Stockhouse, Real Investment Advice, OTCPicks, AllPennyStocks, GuruFocus, MicrocapVoice, Equities, Marketwired, SmallCapVoice, The Street, InvestorsHub, Stockopedia, Wallet Investor, and Morningstar reported earlier on Digerati Technologies, Inc. (DTGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Digerati Technologies, Inc. is a diversified holding company listed on the OTC Markets’ OTCQB. It has subsidiary operations in the cloud communications industry. The Company, via its wholly-owned subsidiary, Shift8 Technologies, Inc., provides Internet-based telephony products and services through its cloud telephony application platform and session-based communication network. is headquartered in San Antonio, Texas.

Fundamentally, the Company is an established and award-winning provider of cloud communication services. It serves traditional carriers, telephony resellers, as well as other VoIP (Voice over Internet Protocol) carriers in the United States and worldwide. Digerati Technologies provides VoIP communication services to telecommunications companies. Digerati Technologies completed the acquisition of Synergy Telecom, Inc. in 2017. Digerati’s Shift8 Networks combined Synergy Telecom with its Texas-based business and operations. Synergy Telecom is a foremost provider of cloud communication services in Texas.

In 2018, Digerati Technologies completed the acquisition of T3 Communications, Inc. It stated that this acquisition positions Digerati for hyper-growth in two of the fastest growing sectors of the telecommunications industry, UCaaS (Unified Communications as a Service) and SD-WAN (Software-Defined Wide-Area Network). T3 Communications is a top provider of cloud communications and broadband solutions in Southwest Florida.

Digerati’s Shift8 Networks subsidiary is an enterprise hosted PBX and cloud-based Unified Communications service provider. Shift8 Networks provides voice, video, and mobile communications to thousands of businesses via its Channel Alliance program.

Shift8 integrates hosted VoIP with cloud-based messaging and desktop applications. Its VAR program targets PBX Vendors, Information Technology (IT) Services firms, Managed Service Providers, and Systems Integrators that lack a cloud telephony infrastructure, but have an embedded customer base that needs Internet-based telephony services.

Digerati also provides Internet-based services. These include fully hosted IP/PBX services, IP trunking; call center applications, prepaid services, and interactive voice response auto attendant. Services additionally include call recording, simultaneous calling, voicemail to email conversion, and many customized IP/PBX features in a hosted or cloud environment for specialized applications.

Digerati has launched a mobile ‘business continuity’ solution in partnership with Otarris, a division of Kajeet, Inc., for addressing the increasing demand for disaster recovery networks in the enterprise marketplace. Digerati is addressing the growing need for its customers to deploy a redundant and diverse bandwidth solution for ‘business continuity’ during primary network outages. These include those caused by natural or human-induced disasters.

Last month, Digerati Technologies announced that it entered into an agreement to acquire a minority ownership stake in Itellum Comunicaciones Costa Rica S.R.L. Itellum is a fully licensed telecommunication and Internet Service Provider. With this agreement, Digerati expands its long-standing relationship with Itellum, a regional Partner and VAR (Value-Added Reseller) for its cloud communication services. Digerati's purchase of a minority stake secures Itellum as the exclusive provider of Digerati's services. It also positions Digerati Technologies to better serve Central America.

Digerati Technologies, Inc. (DTGI), closed Monday's trading session at $0.20, even for the day, on 14,686 volume with 8 trades. The average volume for the last 3 months is 40,728 and the stock's 52-week low/high is $0.07/$0.57.

chart

Integrated Cannabis Company, Inc. (ICNAF)

Awesome Penny Stocks, Market News Updates, Wallet Investor, Trading View, The Venture Report, Market Chameleon, BioSpace, Wallstreet Online, Investors Hangout, MarketWatch, InvestorsHub, Stockwatch, Stockhouse, OTC Markets, CannaBizNetwork, and Barchart reported previously on Integrated Cannabis Company, Inc. (ICNAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Integrated Cannabis Company, Inc.’s focus is health and creating health and lifestyle products utilizing advanced delivery systems and formulations. The Company comprises dedicated scientists and product engineers. It was previously known as CNRP Mining, Inc. It changed its name to Integrated Cannabis Company, Inc. in June of last year. Integrated Cannabis Company is based in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s X-SPRAYS™ product line consists of eight market ready orally ingested spray products. Four products available are infused with hemp-based cannabidiol (CBD). Four products are formulated without a cannabidiol (CBD) infusion.

The products are highly bioavailable; the active ingredients in the sprays are already completely dissolved. Therefore, the vitamins and minerals do not need to be further broken down once swallowed. They are immediately available for use by the body.

The X-SPRAYS™ product line is packaged in precise, metered dose and convenient spray tubes. This includes a child-resistant version. Integrated Cannabis Company’s products are made in Arizona. Its CBD is hemp derived from Colorado.

In September 2018, Integrated Cannabis Company announced the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in the State of Colorado. The THC product uses the same nanotechnology used to enhance the CBD-infused X-SPRAYS™. This results in higher bioavailability and quicker uptake in comparison to capsules or powder.

Recently, Integrated Cannabis Company announced that X-SPRAYS™ successfully exhibited at the 2019 Athens Cannabis Expo in Greece in January at the Tae Kwon Do Convention Center in Athens, Greece. The Expo took place January 11-13, 2019 in Athens. It attracted industry leaders from across the European Union (EU) and other parts of the world.  X-SPRAYS™ was on display and the Company’s sales team successfully educated the public on their novel formulations and delivery method.

Mr. John Knapp, Integrated Cannabis Company’s Chief Executive Officer, said, “The Athens Cannabis Expo was an excellent opportunity for X-SPRAYS™ to network with EU cannabis businesses and to expand our European distribution channels.The European market showed us great promise in 2019 for CBD products. We are positioning ourselves to take full advantage of the changing landscape this year and believe Europe will be a pivotal component for our growth.”

Integrated Cannabis Company, Inc. (ICNAF), closed Monday's trading session at $0.235, up 1.95%, on 75,528 volume with 56 trades. The average volume for the last 3 months is 155,667 and the stock's 52-week low/high is $0.209/$1.58.

chart

PharmaCyte Biotech, Inc. (PMCB)

SmallCapNetwork, MyBestStockAlerts, Wall Street Corner, Penny Stock General, PennyStockInformer, Cannabis Financial Network News, BUYINS.NET, Fast Money Alerts, Penny Stock Beats, The Stock Psycho, Stock Shock and Awe, OTC Journal, Penny Stock Laboratory, Stock Market Media Group, InvestorPlace, Goldman Small Cap Research, Damn Good Penny Picks, Penny Picks, and Darth Trader reported earlier on PharmaCyte Biotech, Inc. (PMCB), and today choose to report on the Company, here at the QualityStocks Daily Newsletter.

PharmaCyte Biotech, Inc. concentrates on developing targeted treatments for cancer and diabetes applying its signature live cell encapsulation technology, Cell-in-a-Box®. This unique and patented technology is being used as a platform upon which treatments for many kinds of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. A clinical stage biotechnology Company and OTCQB-listed, PharmaCyte Biotech has its corporate office in Silver Spring, Maryland.

The Company is also working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other kinds of solid cancerous tumors. PharmaCyte’s treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or "cancer-killing" form.

The capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. The live-cell encapsulation technology that the Company employs is a way to enclose living cells in protective “cocoons” around the size of the head of a pin. It encapsulates living cells, not drugs. PharmaCyte Biotech is advancing its new treatment for pancreatic cancer into the clinic in the United States, with study sites in Australia and Europe.

Furthermore, the Company is developing treatments for cancer built upon chemical constituents of the cannabis plant, called cannabinoids. PharmaCyte is studying ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects typically associated with cancer treatments.

In January, PharmaCyte Biotech announced that its partner, Austrianova, successfully encapsulated the live cells used in PharmaCyte’s therapy for its planned clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC). The cells are currently growing and dividing inside the Cell-in-a-Box® capsules.

PharmaCyte Biotech’s Chief Executive Officer, Mr. Kenneth L. Waggoner, said, “We are now in the process of monitoring the growth and division of the live cells as they spend more time in a ‘nutrient bath.’ This will allow the cells to continue to grow and divide and then completely fill the capsules. Once the capsules are completely full of live cells, they will be placed into syringes and frozen. Austrianova will then commence testing the capsules in the frozen syringes to finalize PharmaCyte’s clinical trial material.”

PharmaCyte Biotech, Inc. (PMCB), closed Monday's trading session at $0.0549, down 1.08%, on 3,343,387 volume with 134 trades. The average volume for the last 3 months is 1,799,953 and the stock's 52-week low/high is $0.036/$0.105.

chart

Planet 13 Holdings, Inc. (PLNHF)

MicroCap Daily, Wallet Investor, Pot Network, Penny Stock Hub, Markets and Research, InvestorX, MicroSmallCap, Market Screener, Stockhouse, MarketWatch, Dividend Investor, Trading View, Morningstar, Financial Content, and InvestorsHub reported earlier on Planet 13 Holdings, Inc. (PLNHF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Planet 13 Holdings, Inc. is a vertically integrated cannabis company listed on the OTCQB. It has award-winning cultivation, production, and dispensary operations in Las Vegas, Nevada. The Company is an established cannabis leader in the Nevada market. Its emphasis is on providing a premier dispensary experience and optimizing cultivation efficiencies via its best-in-class technology, as the frontline of cannabis. Planet 13 Holdings is headquartered in Las Vegas.

The Company’s mission is to build a recognizable worldwide brand known for first-rate dispensary operations, and a creator of unique cannabis products. On November 1, 2018, Planet 13 opened the largest, most advanced retail dispensary in the world immediately next to the Las Vegas strip. The new facility features 16,200 sq. ft. of dispensary space.

Planet 13 has 6-plus Cannabis Licenses. It is fully licensed for cultivation, retail distribution and more in the fast developing Nevada market. The Company’s Medizin dispensaries provide top quality recreational cannabis, cannabis extracts, and infused products. Medizin also centers on industry-leading customer experiences. It produces flower, concentrates, vape pens, edibles and more. Medizin (Medical) and Planet 13 (Recreational) brands are already some of the most awarded cannabis product brands in Nevada.

Planet 13 announced in November of 2018 that it launched its second wholly-owned brand, TRENDI. TRENDI represents expertly crafted disposable vape and concentrate products. Fundamentally, they create the trend, not the other way around. TRENDI employs state-of-the-art hydro carbon extraction technology further refined by fractional distillation. It delivers a very high potency product. The TRENDI line of products will be exclusive to the Planet 13 Superstore. TRENDI will be powered by a curated array of strains, processed into ultra-premium disposable vapes and concentrates at Planet 13’s production facilities.

Earlier this month, Planet 13 announced that in January it served an average of 1,550 customers per day at its Superstore in Las Vegas versus 1,430 customers per day in December. This represents a month-over-month increase of 8.4 percent. In addition, Planet 13 stated that its average ticket size for the month was higher than expected.

Furthermore, this month, Planet 13 commended the proposal by Governor Sisolak to establish the Cannabis Compliance Board (CCB) that will review recent licensing procedures. This includes the most recent licensing round announced on December 5, 2018. Moreover, the CCB will oversee the development of future legislation including that governing consumption lounges.

Planet 13 Holdings, Inc. (PLNHF), closed Monday's trading session at $1.39, down 2.80%, on 216,058 volume with 205 trades. The average volume for the last 3 months is 169,458 and the stock's 52-week low/high is $0.502/$2.669.

chart

Metalla Royalty & Streaming Ltd. (MTAFF)

MiningFeeds, InsiderFinancial, OTC Markets, Proactive Investors, Junior Mining Network, Stockwatch, and Dividend Investor reported on Metalla Royalty & Streaming Ltd. (MTAFF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Metalla Royalty & Streaming Ltd. formed to provide shareholders with leveraged precious metal exposure through acquiring royalties and streams. The Company has a strong pipeline of transactions with favorable rates of return. Metalla is working to amass a diverse portfolio of royalties and streams with attractive returns.

The Company formerly went by the name Excalibur Resources Ltd. It changed its name to Metalla Royalty & Streaming Ltd. in December 2016. Metalla Royalty & Streaming is based in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQX.

Metalla’s Streams and Royalties include the Endeavor Silver Stream and the NLGM Silver Stream. Furthermore, they include the Joaquin Royalty; the Zaruma Royalty; the Hoyle Pond Extension Royalty; the West Timmins Extension Royalty; and the DeSantis Mine Royalty, and also an assortment of other royalties.

Metalla Royalty & Streaming announced this past May that it acquired a 2 percent Net Smelter Return (NSR) royalty on the Akasaba West Property from Alexandria Minerals Corporation pursuant to a royalty purchase and sale agreement dated May 11, 2018. With this Agreement, Metalla and Alexandria Minerals entered into an assignment and assumption agreement. The Royalty was transferred from Alexandria Minerals to Metalla.

The Akasaba West Property is a gold-copper deposit situated in the Bourlamaque and Louvicourt Townships, Val d’Or, Quebec. The Akasaba West Property is owned and operated by Agnico Eagle Mines Limited.

In 2014, Agnico acquired the project from Alexandria Minerals. Agnico has continued prior permitting and development activities, with a view to commencing mining activities in 2020. The Royalty has been acquired for a total purchase price of $250,000 in cash.

Metalla Royalty & Streaming announced preliminary production results for the twelve months ended May 31, 2018 (Fiscal 2018) of 519,791 ounces (oz.) of attributable silver (Ag), where 429,315 oz. were sold and provisionally invoiced and 90,476 oz. remained as inventory to be realized in the following quarter. Total production surpassed management guidance expectations for Fiscal 2018. Sales were a little below expectations mainly because of unusually high inventory held by the Endeavor mine operator (CBH Resources Limited) at fiscal year-end during its smelter contract re-negotiations.

Recently, Metalla Royalty & Streaming announced the successful completion of the earlier announced plan of arrangement with ValGold Resources Ltd. Metalla has acquired all of the outstanding shares of ValGold via a court-approved plan of arrangement.

Mr. Brett Heath, Metalla President and Chief Executive Officer, stated, "We are very pleased to close this accretive transaction which further broadens our royalty portfolio pipeline in the tier-one jurisdiction of Canada, while preserving our strong balance sheet. With the acquisition of Valgold complete, Metalla will now have a portfolio of 21 royalties and streams on projects ranging from production, development, and exploration from some of the strongest operators in the precious metals mining sector."

ValGold Resources holds a 2 percent Net Smelter Return (NSR) royalty on certain claims of the Garrison Project that encompasses the Garrcon and Jonpol properties, and the eastern portion of the 903 Zone. The Garrison Project is positioned approximately 100 kilometers east of Timmins, Ontario, and 40 kilometers north of Kirkland Lake.

Metalla Royalty & Streaming Ltd. (MTAFF), closed Monday's trading session at $0.88, up 3.53%, on 161,974 volume with 99 trades. The average volume for the last 3 months is 143,881 and the stock's 52-week low/high is $0.4755/$0.90.

chart

MoneyOnMobile, Inc. (MOMT)

Stockflare, Marketwired, Stockopedia, Barchart, The Street, TradingView, YCharts, 4-Traders, OTC Markets, MarketWatch, InvestorsHub, and Morningstar reported on MoneyOnMobile, Inc. (MOMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, MoneyOnMobile, Inc. is one of India's largest mobile phone-based payment networks. The Company facilitates easy, safe, and secure financial transactions to millions of Indians. Its core belief is in providing service to the unbanked consumer, by way of Financial Inclusion and self-dependence.

The Company previously went by the name Calpian, Inc. It changed its corporate name to MoneyOnMobile, Inc. in August 2016. Incorporated in 2006, MoneyOnMobile has offices in Dallas, Texas, and Mumbai, India.

The Company’s services include money transfer, mobile recharge, bill payment, DTH recharge, train tickets, flight tickets, hotel booking, and online shopping. It designed MoneyOnMobile to work across all mobile phone handsets. This is from the most basic to the most advanced.

MoneyOnMobile continually innovates to provide a range of innovative solutions together with its continuous, premier, 24 x 7 transactional convenience via a simple SMS, Application and Web Portal. 

MoneyOnMobile has authorization by the Reserve Bank of India (RBI) to set up a semi-closed payment system in India. This system enables registered users to buy goods, products, and services from registered Merchants. MoneyOnMobile provides a broad array of services on a real-time basis, irrespective of geography, time, and mobile operator.

MoneyOnMobile announced in June the launch of the Reserve Bank of India's payment service (Bharat Billpay) through the MoneyOnMobile retailer platform. The launch of the new service enables its retailers to meet the growing demand for digital payment services among the estimated 600-800 million unbanked/underbanked population of India and increase the monthly spend of its existing customers.

Earlier this month, MoneyOnMobile announced the number of MOM ATM units deployed in India has surpassed the 10,000-unit mark.

Mr. Harold Montgomery, MoneyOnMobile’s Chairman and Chief Executive Officer, said, "We are pleased with the progress of our MOM ATM deployments. Crossing the 10,000-unit mark demonstrates, we believe, strong demand for this product by our retailers. We are well on our way to reaching our goal of 30,000 MOM ATM units deployed by the end of 2019. This is the first step in the cycle of deployment activation and revenues.”

MoneyOnMobile, Inc. (MOMT), closed Monday's trading session at $0.18, up 19.21%, on 5,800 volume with 1 trade. The average volume for the last 3 months is 9,913 and the stock's 52-week low/high is $0.15/$10.60.

chart

NaturalShrimp, Inc. (SHMP)

ThePennyPicks, PennyPickGains, SmallCapVoice, Pennystockmania, and WallstreetSurfers reported on NaturalShrimp, Inc. (SHMP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

NaturalShrimp, Inc. is a global leader in aquaculture technology. The Company has developed and tested the first commercially-viable system for growing shrimp indoors. This system utilizes a proprietary technology to reliably produce healthy, naturally-grown shrimp weekly without the use of antibiotics or toxic chemicals. OTCQB-listed, NaturalShrimp is headquartered in La Coste, Texas.

NaturalShrimp, Inc. owns 100 percent of NaturalShrimp Corporation, created to operate in the U.S. and Canada, and 100 percent of NaturalShrimp Global, Inc., established to create International Joint Venture (JV) Partnerships. The Company’s production facility is outside of San Antonio, Texas. Its European partner has built a production facility in Medina del Campo, Spain. Expansion plans include domestic and international production facilities and distribution channels.

NaturalShrimp has developed a technology to produce fresh, gourmet-grade shrimp dependably and economically in an indoor, re-circulating, saltwater facility. The Company’s eco-friendly, bio-secure design does not rely on ocean water. It recreates the natural ocean environment allowing for high-density production that can be replicated anywhere in the world.

The NaturalShrimp Automated Monitoring and Control system employs individual tank monitors to automatically control the feeding, the oxygenation, as well as the temperature of each of the facility tanks independently. Furthermore, a facility computer, running custom software, communicates with each of the controllers and performs additional data acquisition functions, which can report back to a supervisory computer from anywhere in the world. The computer automated water controls optimize the growing conditions for the shrimp as they mature to harvest size. This provides a disease-resistant production environment.

NaturalShrimp, along with its technology partner F&T Water Solutions, LLC, has teamed with Filtertech, Inc. on manufacturing the production equipment package to initially be deployed at NaturalShrimp’s La Coste facility. The proprietary equipment package is the foundation of the Company’s patented technology. The equipment covers NaturalShrimp’s base process of growing healthful, naturally grown shrimp without the use of chemicals and/or antibiotics.

Last month, Natural Shrimp announced that it is currently working with the HART team in supplying waste data for the creation of a formal shrimp aquaculture solution. Gray CC Ventures, Strategic Sustainable Support (S3), BCH Sustainable Energy Partners, and Trane have been developing a best-practices quality framework named HART (Humane, Accountable and Renewable Technologies), for the agriculture livestock industry. Each of the participating team members is responsible for a particular part of the program. This includes diet, humane care and harvesting of the livestock, engineering, and waste-to-energy (the conversion of waste products into useful commodities, including pet food feedstock, compost, and renewable energy).

Mr. Gerald Easterling, NaturalShrimp’s President, said, "We are excited to be assisting the HART team in the aquaculture arena. As aquaculture grows over the next several years, it is important that it continues to support the long term viability of the environment. We have over 16 years of data that has been recorded since our inception in 2001. This information should prove invaluable to the team."

NaturalShrimp, Inc. (SHMP), closed Monday's trading session at $0.55, up 31.55%, on 13,751,049 volume with 2,982 trades. The average volume for the last 3 months is 16,519,350 and the stock's 52-week low/high is $0.0049/$0.949.

chart

Liquidmetal Technologies, Inc. (LQMT)

Greenbackers, SmallCapVoice, PennyStocks24, Pennybuster, Marketbeat.com, Jason Bond, Promotion Stock Secrets, Penny Pro, Winston Small Cap, Wall Street Mover, SuperNova Elite, Wealth Daily, PennyStocks Forever, and Penny Stocks VIP reported on Liquidmetal Technologies, Inc. (LQMT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal® Technologies, Inc. is the foremost developer of bulk alloys, which utilize the performance advantages that amorphous alloy technology provides. Amorphous alloys are unique materials distinguished by their ability to retain a random structure when they solidify. This is in comparison to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal® Technologies has its headquarters in Rancho Santa Margarita, California, where it also has its Manufacturing Center of Excellence. The Company’s shares trade on the OTC Markets.

Liquidmetal Technologies is the first company to produce amorphous alloys in commercially viable bulk form. This is enabling critical improvements in products across a wide array of industries.

Liquidmetal has two to three times the strength of titanium and stainless steel. It undergoes processing alike to plastics on the Company's proprietary Liquidmetal molding machines. The Company’s class of patented alloys and processes form the foundation of high performance materials used in a broad spectrum of medical, military, consumer, and industrial, and sporting goods products.

Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal® Technologies’ alloys are, in many cases, stronger, harder, more elastic, and more wear and corrosion resistant than typically used high-performance alloys.

The Company’s "bulk" amorphous alloys possess advantages normally associated with plastics. These include the ability to undergo molding into precision, complex, as well as highly finished products. Liquidmetal® Technologies controls the Intellectual Property (IP) rights with greater than 70 U.S. patents.   

Liquidmetal® Technologies and the University of Southern California’s M.C. Gill Composites Center are working in tandem to develop an advanced manufacturing process to produce large-scale amorphous metal and fiber laminate sheets for space applications. The work is funded by a NASA SBIR (Small Business Innovation Research) Phase I contract addressing solicitation topic number Z2.01, “Cross cutting advanced manufacturing process for large scale bulk metallic glass systems for aerospace applications.”

Professor Lugee Li, Chairman and Chief Executive Officer at Liquidmetal® Technologies was presented with an Excellence Award from the International Magnesium Association (IMA) at the 2017 World Magnesium Conference, which took place in Singapore on May 21-23, 2017. This Excellence Award was presented to Professor Li in recognition of a new automotive cast design for structural portions of automotive closure panels (side doors, lift gates, hoods, trunk lids) where his innovative, novel, and creative design and development of magnesium demonstrated considerable advances over existing practice.

In Q2 2017 Liquidmetal® Technologies received two hot crucible amorphous metal molding machines from its licensing partner Eontec Ltd. The machines permit the production of amorphous alloy parts, which are up to three times larger and one-third the cost of established technologies. The Company also continued the build out of its new manufacturing facility in Q2, which it bought in February of this year.

Liquidmetal Technologies, Inc. (LQMT), closed Monday's trading session at $0.17846, up 8.16%, on 3,646,726 volume with 296 trades. The average volume for the last 3 months is 1,041,105 and the stock's 52-week low/high is $0.10/$0.287.

chart

Magellan Gold Corp. (MAGE)

Penny Stock Pick Alert, RisingPennyStocks, SixFigureStockPicks, Greenbackers, PennyPickAlerts, PennyStockMoneyTrain, Pumps and Dumps, FOX Penny Stocks, Joe Penny Stocks, Liquid Tycoon, Penny Stock Pick Report, Super Hot Penny Stocks, Super Nova Stock Picks, WePickPennyStocks, and Winning Penny Stock Picks reported on Magellan Gold Corp. (MAGE), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Magellan Gold Corp.’s primary business is the acquisition and exploration of mineral resources. The OTCQB-listed Company engages in the acquisition and exploration of precious metals mineral properties. Its updated strategic goal is building a mid-tier precious metals exploration and mining company.  Magellan Gold is headquartered in Vacaville, California.

Magellan has its "Silver District" project. This project consists of 94 unpatented lode mining claims, 6 patented lode claims, an Arizona mining lease of 335 acres, and 23 unpatented mill site claims, totaling greater than 2,000 acres. Magellan Gold holds its properties via its 85 percent owned subsidiary Gulf & Western Industries, Inc.

Its district-scale property position encompasses the core of the historic Silver District in La Paz County, about 50 miles north of Yuma. At the Silver District Project in southwest Arizona, the Company’s goal is to expand its resource base containing an historic resource of 16 million ounces of silver. It also plans to acquire additional advanced-stage properties that have tangible promise for development.   

Magellan Gold has the right to earn an undivided 50 percent interest in the Niñobamba Silver/Gold Project in central Peru. To earn its 50 percent interest, the Company must spend $2.0 million in exploration over three years. The Niñobamba project covers 9,027 acres and demonstrates potential for a large, bulk tonnage, silver-gold deposit.

Rio Silver and its project partner, Magellan Gold, announced this past February that they initiated exploration work on the expanded Niñobamba Project. Recent strategic additions to the land package have created a large, contiguous property comprising 3100 hectares and another 553-hectare concession pending title confirmation. Magellan Gold will be spending US$2 million at the Niñobamba project to earn its 50 percent interest.

Magellan Gold announced that it entered into a Memorandum of Understanding (MOU) with Rose Petroleum plc to purchase an operating floatation plant, which also includes a precious metals leach circuit and associated assets, licenses and agreements (together, the SDA Mill), located in the State of Nayarit, Mexico, for a total consideration of US$1.5 million. The basis of the mill's normal operation is on sales of floatation concentrates to smelters, and payment for precious metals content. The mill currently engages in toll milling for third party ore producers. Rose Petroleum is a multi-asset natural resource enterprise.

Magellan Gold announced it arranged $900,000 in irrevocable bridge loans in support of its option to purchase the SDA Mill from Rose Petroleum. The bridge loans are enough to complete the cash component of the purchase price and have the effect of extending the purchase option until closing of the transaction.

Magellan Gold Corp. (MAGE), closed Monday's trading session at $3.05, up 19.61%, on 3,104 volume with 13 trades. The average volume for the last 3 months is 59,270 and the stock's 52-week low/high is $0.60/$3.79.

chart

Uniroyal Global Engineered Products, Inc. (UNIR)

Zacks, Marketbeat.com, and MarketWatch reported on Uniroyal Global Engineered Products, Inc. (UNIR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Uniroyal Global Engineered Products, Inc., via its subsidiaries, is a top manufacturer of vinyl coated fabrics. These fabrics are durable, stain resistant, cost-effective alternatives to leather, cloth, and other synthetic fabric coverings. The Company is a foremost supplier of these vinyl coated fabric materials for the automotive and commercial industries. Established in 1992, Uniroyal Global Engineered Products (UNIR) is headquartered in Sarasota, Florida.

UNIR’s primary brand names include Naugahyde®, BeautyGard®, Flameblocker™, and Spirit Millennium®. Moreover, they include Ambla®, Amblon®, Velbex®, Cirroflex®, Plastolene® and Vynide®.  The Company’s 2016 revenue was derived 65 percent from the automotive industry and roughly 35 percent from the recreational, industrial, indoor and outdoor furnishings, hospitality, and health care markets

UNIR’s products in the automotive industry are used mostly in seating, door panels, head and arm rests, security shades, and trim components. The Company’s non-automotive applications include outdoor seating for utility and sports vehicles, and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pool liners, pram and nursery, movie screen, and decorative surface applications.

UNIR’s Naugahyde brand introduced Casablanca in 2016. This is a linen-textured vinyl-coated fabric. Casablanca combines the look and feel of linen with the performance of Naugahyde®.

The collection was developed with hospitality, contract, marine, as well as healthcare markets in mind. All of Casablanca’s patterns are flame retardant, stain resistant, and anti-microbial. Casablanca features Naugahyde’s exclusive Advanced BeautyGard® top coat finish.

Uniroyal Global Engineered Products, Inc. (UNIR), closed Monday's trading session at $1.30, up 18.18%, on 2,300 volume with 6 trades. The average volume for the last 3 months is 1,496 and the stock's 52-week low/high is $1.00/$2.04.

chart

TSS, Inc. (TSSI)

RedChip, Marketbeat.com, and Wall Street Resources reported on TSS, Inc. (TSSI), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, TSS, Inc. is a data center and mission critical facilities and technology services enterprise. The Company is a single source provider of mission-critical planning, design, system integration, deployment, maintenance, and development of data centers facilities and information infrastructure. TSS is an innovator in the hyper-dynamic mission-critical facilities industry. The Company is based in Round Rock, Texas.

TSS is an innovator and leader in mission-critical infrastructure design and support services. These include Modular Data Centers, Assessments & Audits, Design & Budgeting, Project & Construction Services, Operations & Maintenance, and Planning & Analysis or Transformation Services. Its Data Center Services include Modular Data Centers; Data Center Health Check; Facility Assessment; Owners Representation; Strategic Options Analysis; CFD Assessment; Data Center Transition Planning; Information Technology (IT) Equipment Relocation Services; and Arc Flash-Hazard Analysis.

TSS has worked across numerous industries. The Company has planned, designed, built, as well as maintained specialized facilities. These include data centers, communications rooms, SCIFs, call centers, laboratories, trading floors, network operations centers, and medical facilities.

The Company provides a single-source solution for mission-critical facilities. It specializes in customizable end-to-end solutions powered by industry experts and creative services. These include technology consulting, engineering, design, project management, operations, facilities management, technology system installation and integration, and maintenance for traditional and modular data centers.

TSS integrates a facility’s electrical, mechanical, security, and building envelope into a unified strategic asset. The Company’s goal is to provide its customers with the most advanced and reliable mission-enabling solutions. Its expertise is in IT and integrated facilities services. The Company provides end-to-end solutions for all facets of a client’s critical facility projects.

An example of TSS’s solutions is the above-mentioned Modular Data Centers (MDCs). The Company provides MDC solutions, which help customers’ to cost-effectively design and deploy a data center founded on quality, scalability, maintainability, and portability. TSS can provide a customer with design, engineering, installation, and maintenance services to configure and support solutions unique to their requirements.

Concerning MDC Pre-Deployment, the Company offers Site Assessment, Site Design, and IT Integration. Regarding Deployment, it offers Site Preparation; Receiving; Rigging; Assembly/Connections; and Commissioning. Concerning Post-Deployment, it offers Warranty and Preventative Maintenance & Break/Fix Services.

TSS, Inc. (TSSI), closed Monday's trading session at $0.92, up 5.75%, on 8,000 volume with 11 trades. The average volume for the last 3 months is 14,893 and the stock's 52-week low/high is $0.35/$1.09.

chart

The QualityStocks Company Corner

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company the Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) recently issued an update regarding the construction at its Valleyfield, Quebec, and Hamilton, Ontario, facilities. To view the full article, visit: http://nnw.fm/8Uf3G.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.91, up 3.53%, on 1,340,564 volume with 1,776 trades. The average volume for the last 3 months is 962,653 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) ("TCAN" or the "Company"), is a Canadian based company providing branding, transportation, and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace, announced today that James Pakulis, President and Chief Executive Officer, will present at the upcoming Gravitas Growth Conference, which is being held on February 28th, 2019 at the Fairmont Pacific Rim Hotel in Vancouver.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $2.89, up 5.86%, on 64,901 volume with 55 trades. The stock's 52-week low/high is $0.769/$2.90.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a food bioscience company that developed and commercialized cost-effective drug delivery platform DehydraTECH. This technology enhances the performance of beneficial compounds in ingestible products.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.41, up 2.17%, on 130,149 volume with 159 trades. The average volume for the last 3 months is 189,783 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Standard Lithium Ltd. (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L) announces that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (collectively, the "Underwriters") pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to a short form prospectus, 10,500,000 units (the "Units") of the Company at a price of $1.00 per Unit (the "Offering Price") for gross proceeds of $10,500,000 (the "Underwritten Offering"). The net proceeds from the Offering are expected to be used by the Company for advancing its existing asset portfolio and for general working capital purposes. Closing of the Offering is expected to take place on or about March 19, 2019 and is subject to certain conditions including, but not limited to the receipt of all applicable regulatory approvals including approval of the TSX Venture Exchange.

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Leadership

Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $0.8435, up 2.19%, on 98,115 volume with 72 trades. The average volume for the last 3 months is 49,383 and the stock's 52-week low/high is $0.59/$1.92.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com Inc. (OTCQB: CIIX) has moved to rebrand subsidiary ChineseHempOil.com Inc.’s consumer products line under the new ‘opt’ brand. The brand unifies its domestic industrial hemp-infused consumer products and features two lines: opt Hemp and opt2mist (http://nnw.fm/eOY6e).

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.494, up 6.21%, on 80,816 volume with 71 trades. The average volume for the last 3 months is 96,845 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) was featured today in the 420 with CNW by CannabisNewsWire. You may be wondering what becomes of the medical marijuana programs and products once a jurisdiction legalizes recreational pot. Some people even conclude that medical marijuana dies quietly once recreational cannabis becomes legal. Is this true?

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.11, even for the day, on 56,047 volume with 275 trades. The average volume for the last 3 months is 109,255 and the stock's 52-week low/high is $3.75/$14.38.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) yesterday announced that its client, Wildflower Brands, was selected to provide gifts for the nominees, presenters and talent staying at the luxury Four Seasons Hotel Los Angeles for the 2019 Oscars. To view the full press release, visit: http://nnw.fm/sX9b9.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.1873, even for the day. The average volume for the last 3 months is 210 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) concentrates on providing first-rate medical devices that address dermatological needs. At present, the company has two products on the market and one in the research and development phase. Its portfolio includes products, devices and treatments that have cosmetic and medicinal or therapeutic benefits. Based in Toronto, Ontario, Therma Bright has significant investments in intellectual property and R&D.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.0099, even for the day, on 152,200 volume with 8 trades. The average volume for the last 3 months is 89,627 and the stock's 52-week low/high is $0.0098/$0.029.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) is focused on cannabis, industrial hemp and cannabinoid research and development; nutraceuticals; pharmaceuticals; and medical devices. The company is nearing completion of its first commercial batch of Hygee, a new original medical device to fight STIs. This self-sampling kit provides women with a discreet and effective way to anonymously test for STIs such as chlamydia.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.64, off by 1.54%, on 24,141 volume with 24 trades. The average volume for the last 3 months is 34,386 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Premium functional food and beverage company Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) this morning announced its entry into a new partnership with Flora Research Laboratories (“FRL”), a leading provider of analytical testing and consulting services to the natural products, active hemp extract (hemp CBD) and dietary supplements industry. To view the full press release, visit: http://nnw.fm/Xkj26.

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.

Regulations

Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.40, off by 4.79%, on 73,280 volume with 43 trades. The average volume for the last 3 months is 36,381 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB: SING), a technology company providing mobile payments and ancillary cannabis services, is positioned to take advantage of the newly legalized U.S. hemp industry with its growing portfolio of hemp and cannabidiol (“CBD”) products, available through subsidiary SingleSeed.com. In an investor update, SinglePoint President Wil Ralston shared the company’s immediate plans to expand its offerings in the CBD space, which has seen a significant boost since the 2018 Farm Bill passed Congress and was signed by President Donald Trump (http://nnw.fm/Bpq4R).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0174, off by 5.95%, on 3,377,416 volume with 147 trades. The average volume for the last 3 months is 6,065,410 and the stock's 52-week low/high is $0.0106/$0.071.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) recently made strides to improve its brand presence by gaining celebrity access through Super Bowl and pre-Academy Awards events. The events served as a great opportunity for the company, where recognized professional athletes and celebrities were able to experience the benefits of the company’s high-quality hemp and cannabidiol (“CBD”)-infused products. To view the full article, visit: http://nnw.fm/Ghu1P.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0135, off by 3.57%, on 5,849,286 volume with 284 trades. The average volume for the last 3 months is 14,066,348 and the stock's 52-week low/high is $0.0115/$0.0499.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.77, up 3.55%, on 247,360 volume with 160 trades. The average volume for the last 3 months is 387,106 and the stock's 52-week low/high is $0.413/$1.89.

Recent News

chart

Cool Events Inc. (RNWR)

The QualityStocks Daily Newsletter would like to spotlight Cool Events Inc. (RNWR).

Cool Events Inc. (RNWR) offers an array of unique, experiential running and obstacle events that attract thousands of participants sharing a passion for running and helping others. The company produced over 120 events in 2018 under the banner of five successful brands and has already lined up venues for 2019.

Cool Events offers the following trademarked events throughout the nation, with each dedicated to raising funds for important charities: Blacklight Run, the largest glow powder run in the world; Bubble Run, the largest daytime 5K run in the country; Foam Glow, The largest nighttime glow run in the country and the world’s only glowing foam run; Blacklight Slide, the first and only close to five story high Glow-N-Dark water slide with neon glowing water; and Terrain Race, the nation’s fastest growing and industry leading obstacle course race for all ages and athletic abilities.

Cool Events dedicates each of its trademarked runs and events to childhood cancer awareness, making sure this critically important issue is spread throughout the nation one runner, one race at a time. Since its first event in August 2013, the company has donated more than $1 million to Phoenix Children’s Hospital/Children’s Miracle Network and hundreds of thousands more to other charity partners such as Ronald McDonald House Charities of New Mexico, Make-a-Wish Foundation, Adoption Awareness, Special Olympics Massachusetts, St. Jude Children’s Research Hospital, Kendra’s Kisses, Boys and Girls Club and many more over the years.

Cool Events brings a seasoned management team with 35 years of combined experience in operating experiential events including obstacle course races, running races, experiential family events and other competitive events. The Cool Events team also offers consulting, marketing and development for outside events. The company’s in-house marketing agency can handle all brand awareness for event strategy, bringing an event’s vision and goals to life.

Cool Events Inc. (RNWR), closed the day's trading session at $0.11, up 10.00%, on 1,100 volume with 2 trades. The average volume for the last 3 months is 29,591 and the stock's 52-week low/high is $0.002/$0.231.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.